UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Shares, par value CHF 0.01 per share EARS The Nasdaq Stock Market LLC FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT ...

Corporate Presentation September 2020 NASDAQ: EARS | Contact: investors@aurismedical.com Innovative Treatments in Neurotology and CNS Disorders Forward-looking Statements This presentation may contain statements that constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are statements other than historical facts and may include statements that address future operating, financi ...

Auris Medical Holding Ltd. (EARS) Q2 2020 Earnings Conference Call September 17, 2020 8:30 AM ET Company Participants Thomas Meyer - Founder, Chairman, CEO & MD Elmar Schaerli - CFO Conference Call Participants Maxim Jacobs - Edison Investment Research Limited Operator Good morning, and welcome to Auris Medical's Conference Call. On today's call are Thomas Meyer, Auris Medical's Chairman and Chief Executive Officer; and Elmar Schaerli, Auris Medical's Chief Financial Officer, who will present the company's ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ OR ☐ SHELL COMPANY REPORT ...

Auris Medical Holding Ltd. (EARS) Q2 2019 Results Earnings Conference Call August 15, 2019 8:00 AM ET Company Participants Thomas Meyer - CEO Hernan Levett - CFO Conference Call Participants Operator Good morning, and welcome to Auris Medical's Conference Call. On today's call, Thomas Meyer, Auris Medical's Chairman and Chief Executive Officer and Hernan Levett, Auris Medical's Chief Financial Officer will present the company's Financial Results for the First Half 2019 and provide a business update. The acc ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ OR o SHE ...

Auris Medical Holding AG (EARS) Q4 2018 Earnings Conference Call March 14, 2019 8:00 AM ET Company Participants Thomas Meyer - CEO Hernan Levett - CFO Conference Call Participants Jim Molloy - AGP Briana Warschun - Edison Group Operator Good morning, and welcome to Auris Medical's Conference Call. On today's call, Thomas Meyer, Auris Medical's Chairman and Chief Executive Officer and Hernan Levett, Auris Medical's Chief Financial Officer will present the company's financial results for the Fourth Quarter an ...

Innovative Treatments for Inner Ear Disorders 4th Quarter 2018 Financial Results & Business Update March 14, 2019 NASDAQ: EARS Forward-looking Statements This presentation and the accompanying oral commentary may contain statements may contain statements that constitute "forwardlooking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are statements other than historical facts and may include stateme ...